Transfer of reboxetine into breastmilk, its plasma concentrations and lack of adverse effects in the breastfed infant

Author： Hackett L.   Ilett Kenneth   Rampono Jonathan   Kristensen Judith   Kohan Rolland  

Publisher： Springer Publishing Company

ISSN： 0031-6970

Source： European Journal of Clinical Pharmacology, Vol.62, Iss.8, 2006-08, pp. : 633-638

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Reboxetine: A Review of its Use in Depression

By Holm K.J.   Spencer C.M.  

CNS Drugs, Vol. 12, Iss. 1, 1999-07 ,pp. : 65-83

Adis International

Access to resources Recommend Favorite

Reboxetine interaction: First reports of interactions with concomitant carbamazepine and phenobarbital leading to decreased serum reboxetine concentrations: 2 case reports

By  

Reactions Weekly, Vol. 1, Iss. 1158, 2007-01 ,pp. : 23-24

Adis International

Access to resources Recommend Favorite

Escitalopram: Lack of adverse effects in a neonate following in utero and breastfeeding exposure: case report

By  

Reactions Weekly, Vol. 1, Iss. 1126, 2006-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

Increased plasma budesonide concentrations in late-stage PBC may be associated with serious adverse events

By  

Inpharma, Vol. 1, Iss. 1399, 2003-01 ,pp. : 20-20

Adis International

Access to resources Recommend Favorite

The Adverse Drug Reactions Advisory Committee (ADRAC) has received 130 adverse drug reaction reports involving reboxetine

By  

Reactions Weekly, Vol. 1, Iss. 1055, 2005-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite